• Two New Buys in the Portfolio, ASML's Recent Nosedive, and an Overvalued AI Stock.

  • 2024/10/26
  • 再生時間: 41 分
  • ポッドキャスト

Two New Buys in the Portfolio, ASML's Recent Nosedive, and an Overvalued AI Stock.

  • サマリー

  • Eric Bleeker and David Hanson address whether ASML is a "Buy" after its recent pullback, discuss the large-cap tech stock most likely to disappoint, break down the implications of using nuclear to power AI, and share the details of Eric's latest buys in the AI portfolio.

    To follow along with the portfolio in real-time, follow Eric and 24/7 Wall Street on X.

    Visit 24/7 Wall St. for all your market and investing news.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Eric Bleeker and David Hanson address whether ASML is a "Buy" after its recent pullback, discuss the large-cap tech stock most likely to disappoint, break down the implications of using nuclear to power AI, and share the details of Eric's latest buys in the AI portfolio.

To follow along with the portfolio in real-time, follow Eric and 24/7 Wall Street on X.

Visit 24/7 Wall St. for all your market and investing news.

Two New Buys in the Portfolio, ASML's Recent Nosedive, and an Overvalued AI Stock.に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。